Ricardo Baptista

Ricardo Baptista has been working in Cell therapy Development and CMC globally, mostly managing teams designing bioprocessing and analytical platforms for the scalable manufacture of allogeneic cell therapies in companies as Procella Tx, Cellectis, CGT Catapult,  and CCRM. He was also involved in the generation and manufacture of clinical-grade iPSC lines, and the design of GMP facilities. Ricardo is a Biotechnology Engineer, obtained his PhD degree in Biotechnology and Biochemical Engineering at Instituto Superior Tecnico, Portugal, and post-doctoral studies at Peter Zandstra’s Stem Cell Bioengineering Lab.